Because of space limitations, only about half of the scientific citations were included in the book Feed Your Genes Right. Below are nearly all of the citations - more than 400 - organized alphabetically for each chapter.
Chapter 1.
Ames BN. Micronutrient deficiencies. A major cause of DNA damage. Annals of the New York Academy of Sciences, 1999;889:87-106.
Anon. Cluster of genes linked with asthma. Reuters Health, June 16, 2003.
Begley S. So much for destiny: even thoughts can turn genes 'on' and 'off.' Wall Street Journal, June 21, 2002:B1.
Blakeslee S. Some biologists ask 'are genes everything?' New York Times, September 2, 1997:B7/
Commoner B. Unraveling the DNA myth. Harper's Magazine, February 2002:39-48.
Kaput J. Diet-disease gene interactions. Nutrition, 2004;20:26-31.
Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiological Genomics, 2004;16:166-177.
Kim YI. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutrition Reviews, 2000;58:205-217.
Moore DS. The Dependent Gene: The Fallacy of Nature vs. Nurture. New York: Henry Holt and Company, 2002.
Nakai H, Montini E, Fuess S, et al. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nature Genetics, 2003;34:297-302.
Pollack A. New era of consumer genetics raises hope and concerns. New York Times, October 1, 2002:D5.
Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003;301:805-809.
Sessler AM, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Journal of Nutrition, 1998;128:923-926.
Turkel H, Nusbaum I. Medical Treatment of Down Syndrome and Genetic Diseases. Southfield, Michigan: Ubiotica, 1985.
Van Ommen B, Stierum R. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Current Opinion in Biotechnology, 2002;13:517-521.
Chapter 2.
Ames BN. Micronutrients prevent cancer and delay aging. Toxicology Letters, 1998;102-103:5-18.
Ames BN, Elson Schwab H, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. American Journal of Clinical Nutrition, 2002;75:616-658.
Arpa J, Cruz-Martinez A, Campos Y, Gutierrez-Molina M, et al. Prevalence and progression of mitochondrial diseases: a study of 50 patients. Muscle Nerve, 2003;28:690-695.
Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proceedings of the National Academy of Sciences, 1997;94:3290-3295.
Culotta E, Koshland DE Jr. DNA repair works it works its way to the top. Science, 1994;266(5193):1926-1929.
DiMauro S. Exercise intolerance and the mitochondrial respiratory chain. Italian Journal of Neurological Science, 1999;20:387-93.
Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. Journal of the American College of Nutrition, 2003;22:118-123.
Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. New England Journal of Medicine, 2004;350:29-37.
Elias P. RNA interference makes strides. Arizona Daily Star, July 19, 2003:A2.
Everson RB, Mehr CM, Erexson GL, et al. Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. Journal of the National Cancer Institute, 1988;80:525-529.
Fosslien E. Mitochondrial medicineÑmolecular pathology of defective oxidative phosphorylation. Annals of Clinical and Laboratory Science, 2001;31:25-67.
Guttmacher AE, Collins FS. Genomic medicineÑa primer. New England Journal of Medicine, 2002;347:15121520.
Harman D. Free radical theory of aging. Mutation Research, 1992;275:257-66.
Harman D. Aging: phenomena and theories. Annals of the New York Academy of Sciences, 1998;854:1-7.
Helzlsouer KJ, Harris EL, Parshad R, et al. DNA repair proficiency: potential susceptibility factor for breast cancer. Journal of the National Cancer Institute, 1996;88:754-755.
Higdon J. An evidence-based approach to vitamins and minerals. Health implicatons and intake recommendations. New York: Thieme, 2003.
Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proceedings of the National Academy of Sciences, 2002;99:16770-5.
Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses. Journal of Orthomolecular Medicine, 1993;8:157-167.
Jackson MJ, McArdle A, McArdle F. Antioxidant micronutrients and gene expression. Proceedings of the Nutrition Society, 1998;57:301-305.
Kopsidas G, Kovalenko SA, Kelso JM, et al., An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle. Mutation Research, 1998;421:27-36.
Kopsidas G, Kovalenko SA, Heffernan DR, et al. Tissue mitochondrial DNA changes. A stochastic system. Annals of the New York Academy of Sciences, 2000;908:226-243.
Koshland DE. Molecule of the year: the DNA repair enzyme. Science, 1994;266:1925.
Kovalenko SA, Kopsidas G, Kelso J, et al. Tissue-specific distribution of multiple mitochondrial DNA rearrangements during human aging. Annals of the New York Academy of Sciences,1998;854:171-181.
Lau NC, Bartel DP.Censors of the genome. Scientific American, August 2003:34-41.
Lee HA, Hughes DA. Alpha-lipoic acid modulates NF-kB activity in human monocytic cells by direct interaction with DNA. Experimental Gerontology, 2002:401-410.
Linnane AW, Kovalenko S, Gingold EB. The universality of bioenergetic disease. Age-associated cellular bioenergetic degradation and amelioration therapy. Annals of the New York Academy of Sciences, 1998;854:202-213.
Linnane AW. Cellular coenzyme Q10 redox poise constitutes a major cell metabolic and gene regulatory system. Biogerontology, 2002;3):3-6.
Liu J, Atamna H, Kuratsune H, et al. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Annals of the New York Academy of Sciences, 2002;959:133-166.
Miller GD, Groziak SM. Diet and gene interactions. Journal of the American College of Nutrition, 1997;16:293-295.
Muller M, Kersten S. Nutrigenomics: goals and strategies. Nature Reviews/Genetics, 2003;4:315-22.
Oltean S, Banerjee R. Nutritional modulation of gene expression and homocysteine utilization by vitamin B12. Journal of Biological Chemistry, 2003;278:20778-20784.
Peregrin T. The new frontier of nutrition science: nutrigenomics. Journal of the American Dietetic Association, 2001;101:1306.
Piechota J, Mroczek K, Bartnik E. MELAS as an example of a mitochondrial disease. Journal of Applied Genetics, 2001;42:351-358.
Sancar A. Mechanisms of DNA excision repair. Science, 1994;266(5193):1954-6.
Sapolsky RM. Why Zebras Don't Get Ulcers: A Guide to Stress, Stress-Related Diseases, and Coping. New York: W. H. Freeman and Company, 1994.
Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB Journal, 1996;10:709-720.
Seppa N. Metal's mayhem. Cadmium mimics estrogen's effects, thwarts DNA repair. Science News, July 19,2003:38.
Szczesny B, Hazra TK, Papaconstantinou J, et al. Age-dependent deficiency in important of mitochondrial DNA glycosylases required for repair of oxidatively damaged bases. Proceedings of the National Academy of Sciences, 2003;100:10670-10675.
Trayhurn P. Nutritional genomicsÑnutrigenomics. British Journal of Nutrition, 2003;89:1-2.
Vu TH, Hirano M, DiMauro S. Mitochondrial diseases. Neurologic Clinics, 2002;20:809-839.
Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis, 1997;18:869-882.
Chapter 3.
Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutation Research, 2001;475:7-20.
Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk? National Review of Cancer, 2002;2:694-704.
Anon. Obesity in U.S. has surged, survey says. Reuters Health, October 8, 2002.
Baschetti R. Genetically unknown foods or thrifty genes? American Journal of Clinical Nutrition, 1999;70:420-425.
Burke W. Genetic Testing. New England Journal of Medicine, 202;347:1867-1875.
Challem JJ. Did the loss of endogenous ascorbate propel the evolution of Anthropoidea and Homo sapiens? Medical Hypotheses, 1997;48:387-92.
Cleland SJ, Petrie JR, Ueda S, et al. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. Clinical and Experimental Pharmacology and Physiology, 1998;25:175-184.
Cordain L. Miller JB, Eaton SB, et al. Plant-animal subsistence ratios and macronutrient energy estimates in worldwide hunter-gatherer diets. American Journal of Clinical Nutrition, 2000;71:682-692.
Dhahbi JM, Kim JH, Mote PL, et al. Temporal linkage between the phenotypic and genomic responses to calorie restriction. Proceedings of the National Academy of Sciences: electronic publication March 22, 2004, ahead of print.
Eaton SB, Eaton SB II. Paleolithic vs. modern dietsÑselected pathophysical implications. European Journal of Nutrition, 2000;39:67-70.
Ely JTA. Glycemic modulation of tumor tolerance. Journal of Orthomolecular Medicine, 1996;11:23-34.
Hursting SD, Lavigne JA, Berrigan D, et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annual Review of Medicine, 2003;54:131-152.
Johnston CS and Thompson LL. Vitamin C status of an outpatient population. Journal of the American College of Nutrition, 1998;17:366-370.
Kaati G, Bygren LO, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. European Journal of Human Genetics, 2002;10:682-688.
Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences, 2003 (early online edition):1531903100.
Kolata G. Low-calorie-diet study takes scientists aback. New York Times, September 19, 2003:A16.
Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB Journal, 1997;11:118-124.
La Vecchia C, Negri E, Franceschi S, et al. A case-control study of diabetes mellitus and cancer risk. British Journal of Cancer, 1994;70:950-953.
Lev-Ran A. Mitogenic factors accelerate later-age diseases: insulin as a paradigm. Mechanisms of Aging and Development, 1998;102:95-113.
Mattison JA, Lane MA, Roth GS, et al. Calorie restriction in rhesus monkeys. Experimental Gerontology, 2003;38:35-46.
O'Connor A. Study details 30-year increase in calorie consumption. New York Times, February 6, 2004:A19.
Pauling L, Orthomolecular Medicine. Science, 1968;160:265-271.
Rao KS. Dietary calorie restriction, DNA-repair and brain aging. Molecular and Cellular Biochemistry, 2003;253:313-318.
Szent-Gyšrgyi A.V. On Vitamins, Health and Disease. In On Oxidation, Fermentation, Vitamins, Health and Disease, Baltimore, Williams & Wilkins Co., 1939:88-109.
Waterland RA, Jirtle RL. Transposable elements: targets for early nutrition effects on epigenetic gene regulation. Molecular and Cellular Biology, 2003;23:5293-5300.
Williams WJ. Biochemical Individuality: The Basis for the Genetotrophic Concept. New York: John Wiley & Sons, 1956.
Wright JD, Kennedy Stephenson J, Wang CY, et al. Trends in intake of energy and macronutrientsÑUnited States, 1971-2000. Morbitidy and Mortality Weekly Report, February 6, 2004;53:80-82.
Zhang D, Okada S, Yu Y, et al. Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron mediated peroxidation in wistar rat kidney. Cancer Research, 1997;57:2410-2414.
Chapter 4.
Barbiroli B, Medori R, Tritschler HJ, et al. Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy. Journal of Neurology, 1995; 242:472-7.
Barbiroli B, et al. Thioactic acid stimulates muscle ATP production in patients with Type-2-Diabetes and Diabetic polyneuropathy. Diabetes und Stoffweschsel, 1996;5(Supplement-Heft 3):71-76.
Bliznakov EG, Wilkins DJ. Biochemical and clinical consequences of inhibiting coenzyme Q10 biosynthesis by lipid-loering HMG-CoA reductase inhibitors (statins): a critical overview. Advances in Therapy, 1998;15:218-228.
Campos Y, et al. Plastma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle & Nerve, 1993,16:150-3.
Folkers K, Hanioka T, Xia LJ, McRee JT Jr, Langsjoen P. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex. Biochemical and Biophysical Research Communications, 1991;176(2):786-91.
Folkers K, Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biocheimica et Biophysica Acta, 1995;1271-281-286.
Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome, Annals of Allergy, Asthma, and Immunology, 1999;82:185-191
Gordon A, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovascular Research, 1995;30:413-418.
Hagen TM, Liu J, Lukkesfeldt J, et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proceedings of the National Academy of Sciences of the USA, 2002;99:1870-1875.
Johnston CS, Swan PD, Corte C. Substrate utilization and work efficiency during submaximal exercise in vitamin C depleted-repleted adults. International Journal of Vitamin and Nutrition Research, 1999;69:41-44.
Langsjoen PH, Langsjoen AM. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. BioFactors, 2003;18:101-111.
Lockwood K, Moesgaard S, Yamamoto T, et al. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications, 1995;212:172-177.
Lodi R, Iotti S, Scorolli L, Set al. The use of phosphorus magnetic resonance spectroscopy to study in vivo the effect of coenzyme Q10 treatment in retinitis pigmentosa. Molecular Aspects of Medicine, 1994;15 (Suppl):S221-30.
Mizuno M, Quistorff B, Theorell H, et al. Effects of oral supplementation of coenzyme Q10 on 31P-NMR detected skeletal muscle energy metabolism in middle-aged post-polio subjects and normal volunteers. Molecular Aspects of Medicine, 1997;18 (Suppl):S291-S298.
Musumeci O, Naini A, Slonin AE, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology, 2001;56:849-855.
Plioplys AV and Sigita Plioplys. Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology, 1997;35:16-23.
Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease. Evidence of slowing of the functional decline. Archives of Neurology, 2002;59;1541-1550.
Suzuki YJ, Aggarwal BB, Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochemical and Biophysical Research Communications, 1992;189:1709-15.
Klivenyt P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine, 1999; 5:347-350.
Kuratsune H, et al. Acylcarnitine deficiency in chronic fatigue syndrome. Clinical Infectious Diseases, 1994;18 (Suppl 1)S62-7.
Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences, 1996;93:3704-3709.
Liu J, Head E, Gharib AM, et al. Memory loss in old rats is associated with brain mitochondreial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-a-lipoic acid. Proceedings of the National Academy of Sciences, 2002;99:2356-2361.
Liu J, Killilea DW, Ames BN. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-a-lipoic acid. Proceedings of the National Academy of Sciences of the USA, 2002;99:1876-1881.
Naylor GJ, Grant L, Smith C. A double blind placebo controlled trial of ascorbic acid in obesity. Nutrition and Health, 1985;4:25-28.
Omran H, Illien S, MacCarter D, et al. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. European Journal of Heart Failure, 2003;5:615-9.
Stockler S, et al. Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet, 1996;348:789-790.
Tarnopolsky M and Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology, 1999;52:854-7.
Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology, 1996;47:705-711.
Van Gammerren D, Falk D, Antonio J. The effects of four weeks of ribose supplementation on body composition and exercise performance in healthy, young, male recreational bodybuilders: a double-blind, placebo-controlled trial. Current Therapeutic ResearchÑClinical and Experimental, 2002;63:486-495.
Volek JS, et al. Creatine supplementation enhances muscular performance during high-intensity resistance exercise. Journal of the American Dietetic Association, July 1997;97:765-770.
Ziegenfuss TN, Rogers M, Lowery L, et al. Effect of creatine loading on anaerobic performance and skeletal muscle volume in NCAA division 1 athletes. Nutrition, 2002;18:397-402.
Chapter 5.
Ames BN. Cancer prevention and diet: help from single nucleotide polymorphisms. Proceedings of the National Academy of Sciences, 1999;96:12216-12218.
Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proceedings of the National Academy of Sciences, 1997;94:3290-3295.
Collins AR, Harrington V, Drew J, et al. Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis, 2003;24:511-515.
Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. Journal of Nutrition, 2002;132:2392S-2400S.
Everson RB, Mehr CM, Erexson GL, et al. Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. Journal of the National Cancer Institute, 1988;80:525-529.
Fenech MF, Dreosti IE, Rinaldi JR. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis, 1997;18:1329-1336.
Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis, 1998;19:1163-1171.
Jacobson EL. Niacin deficiency and cancer in women. Journal of the American College of Nutrition, 1993;12:412-416.
Jacobson EL, Dame AJ, Pyrek JS, et al. Evaluating the role of niacin in human carcinogenesis. Biochemie, 1995;77:394-398.
Jefferson LS, Kimball SR. Amino acids as regulators of gene expression at the level of mRNA translation. Journal of Nutrition, 2003;133(Suppl):2046S-2051S.
Johanning GL, Heimburger DC, Piyathilake CJ. DNA methylation and diet in cancer. Journal of Nutrition, 2002;132:3814S-3818S.
Kerins DM, Koury MJ, Capdevila A, et al. Plasma S-adenosylmethionine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. American Journal of Clinical Nutrition, 2001;74:723-729.
Kimura M , Umegaki K, Higuchi M, et al. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. Journal of Nutrition, 2004;134:48-56.
Schnyder G, Roffi M, Flammer Y, et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamn B6 on clinical outcome after percutaneous coronary intervention. The Swiss heart study: A randomized controlled trial. JAMA, 2002;288:973-979.
Spronck JC, Batleman AP, Boyonoski AC, et al. Chronic DNA damage and niacin deficiency enhance cell injury and cause unusual interactions in NAD and Poly(ADP-ribose) metabolism in rat bone marrow. Nutrition and Cancer, 2003;45:124-131.
Webster RP, Gawde MD, Bhattacharya RK. Modulation of carcinogen-induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Letters, 1996;98:129-135.
Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 2002;325:1202-1208.
Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Molecular and Cellular Biology, 2003;23:5293-5300.
Woo KS, Chook P, Chan LLT, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. American Journal of Medicine, 2002;112:535-539.
Chapter 6.
Anon. The E in Hearts. TIME, June 10, 1946:45-48.
Archer SY, Meng S, Shei A, et al.. p21 WAFI is required for butyrate-mediated growth inhition of human colon cancer cells. Proceedings of the National Academy of Sciences of the USA, 1998;95:6791-6796.
Beck MA, Shi Q, Morris VC, et al. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Medicine, May 1995;1:433-6.
Bertram JS. Carotenoids and gene regulation. Nutrition Reviews, 1999.57:182-191.
Challem JJ. Did the loss of endogenous ascorbate propel the evolution of Anthropoidea and Homo sapiens? Medical Hypotheses, 1997;48:387-92.
Challem JJ, Taylor EW. Retroviruses, ascorbate, and mutations, in the evolution of Homo sapiens. Free Radical Biology and Medicine, 1998;25:130-2.
Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 1996;276:1957-1963
Cooke MS, Evans MD, Podmore ID, et al. Novel repair action of vitamin C upon in vivo oxi-dative DNA damage. FEBS Letters, 1998;363:363-367.
De Flora S, Cesarone CF, Balanksy R, et al. Chemopreventive properties and mechanisms of N-acetylcysteine. The Experimental Background. Journal of Cellular Biochemistry, 1995; Suppl 22:33-41.
De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity withlong-term N-acetylcysteine treatment. European Respiratory Journal, 1997;10:1535-1541.
Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radical Biology & Medicine, 2000; 29:790-792.
Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet, 1999;354:2048-2049.
Dusinska M, Kazimirova A, Barancokova, M, et al. Nutritional supplementation with antioxidants decreases chromosomal damage in humans. Mutagenesis, 2003;18:371-376.
Edmonds SE, Yinyard PG, Guo R, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Annals of the Rheumatic Diseases, 1997;56:649-655.
Emerit I, Oganesian N, Sarkisian T, et al. Clastogenic factors in the plasma of Chernobyl accident recovery workers: anticlastogenic effect of Ginkgo biloba extract. Radiation Research, 1995;144:198-205.
Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer's disease. JAMA, 2002;287:3223-3229.
Fotherby MD, Williams JC, Forster LA, et al. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. Journal of Hypertension, 2000;18:411-415.
Frydoonfar HR, McGrath DR, Spigelman AD. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin. Colorectal Diseases, 2003;5:149-52.
Fuller CJ, Huet BA, Jialal I. Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation. American Journal of Cardiology, 1998;81:231-233.
Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and reintol in relation to risk of prostate cancer. Journal of the National Cancer Institute, 1995;87:1767-1776.
Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. Journal of the National Cancer Institute, 1999;91:317-331.
Guthrie N, Carroll KK. Inhibition of mammary cancer by citrus bioflavonoids. In Flavonoids in the Living System (Manthey and Busling, eds). New York: Plenum Press, 1998:227-236.
Haney DQ. Tomato nutrient may fight cancer. Associated Press, April 13, 1999.
Helmy M, Shohayeb M, Helmy MH, et al. Antioxidants as adjuvant therapy in rheumatoid diseaseÑa preliminary study. Arzneimittel-Forschung/Drug Research, 2001;51:293-298.
HemilŠ H. Does vitamin C alleviate the symptoms of the common cold? A review of current evidence. Scandinavian Journal of Infectious Diseases, January 1994;26:1-6.
Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV diseae. Proceedings of the National Academy of Sciences of the USA, 1997;94:1967-72.
Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 1997;275:1649-52
Jackson MJ, McArdle A, McArdle F. Antioxidant micronutrients and gene expression. Proceedings of the Nutrition Society, 1998;57:301-305.
Jagetia GC, Venkatesha VA, Reddy TK. Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis, 2003;18:337-343.
Khaw KT, Bingham S, Welch A, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet, 2001;357:657-663.
Kim JM, White RH. Effect of vitamin E on the anticoagulant response to warfarin. American Journal of Cardiology, 1996;77:545-6.
Kucuk O, Sarkar FH, et al. Effects of lycopene supplementation in patients with localized prostate cancer. Experimental Biology and Medicine, 2002;227(10):881-885.
Mitamura T, Tsunoda S, and Nagasawa H. Lycopene, a carotenoid, suppresses TGFa mRNA expression in spontaneous mammary tumours of SHN mice. Bulletin of the Faculty of Agriculture, Meiji University, 1996;108:45-48.
Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer's disease in a biracial community study. JAMA, 2002;287:3230-3237.
Morris MC, Evans DA, Bienias JL, et al. Vitamin E and cognitive decline in older persons. Archives of Neurology, 2002;59:1125-1132.
Nelson HK, Shi Q, Van Dael P, et al. Host nutritional selenium status as a driving force for influenza virus mutations. FASEB Journal, 2001;15:1481-1483.
Ortega RM, Requejo AM, Lopez-Sobaler AM, et al. Cognitive function in elderly people is influenced by vitamin E status. Journal of Nutrition, 2002;132:22065-2068.
Padayatty SJ, Levine M. New insights into the physiology and pharmacology of vitamin C. Canadian Medical Association Journal, 2001;164:353-355.
Palmer HJ, Paulson KE. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutrition Reviews, 1997;55:353-361.
Rihn B, Saliou C, Bottin MC, et al. From ancient remedies to modern therapeutics: pine bark uses in skin disorders revisited. Phytotherapy Research, 2001;15:76-78.
Rudolph RE, Vaughan TL, Kristal AR, et al. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. Journal of the National Cancer Institute, 2003;95:750-757.
Salious C, McLaughlin L, Packer L. French Pinus maritima bark extract prevents ultraviolet-induced NF-kB-dependent gene expression in a human keratinocyte cell line. Presented at Oxidants and Antioxidants in Biology, Oxygen Club of California 1999 World Congress, March 3-6, 1999, Santa Barbara, California.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine, 1997;336:1216-1222.
Schmandke H. Dlimonene in citrus fruit with anticarginogenic action. Ernahrungs-Unschau, 2003;50:264-266.
Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB Journal, 1996;10:709-720.
Stivala LA, Savio M, Quarta A, et al. The antiproliferative effect of _-carotene requires p21 waf1/cip1 in normal human fibroblasts. European Journal of Biochemistry, 2000;267:2290-2296.
Sweetman SF, Strain JJ, McKelvey-Martin VJ. Effect of antioxidant vitamin supplementation on DNA damage and repair in human lymphoblastoid cells. Nutrition and Cancer, 1997;27:122-130.
Takahashi T, Schulze C, Lord B, et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, March 31, 2003: electronic publication in advance of print.
Taylor EW, Ramanathan CS, Jalluri RK, et al. A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by robosomal frameshifting and termination suppression. Journal of Medicinal Chemistry, 1994;37:2637-54.
Torbergsen AC, Collins AR. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. European Journal of Nutrition, 2000;39:80-85.
Upritchard JE, Sutherland WHF, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care, 2000, 23:733-738.
Ursini F, Heim S, Kiess, et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science, 1999;285:1393-1396.
Valigra L. Vitamin E may stop Alzheimer's cell death. UPI newswire, August 27, 1999.
Virgili F, Kobuchi H, and Packer L. Procyanidins extracted from Pinus maritima (Pycnogenol [R] ): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine raw 264.7 macrophages. Free Radical Biology & Medicine, 1998;24:1120-1129.
Vogelsang A, Shute EV. Effect of vitamin E in coronary heart disease. Nature, 1946;157:772.
Watanabe CMH, Wolffram S, Ader P, et al. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proceedings of the National Academy of Sciences, 2001;98:6577-6580.
Yokoyama T, Date C, Kokubo Y, et al. Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community: the Shibata study. Stroke, 2000;31:2287-2294.
Zandi PP, Anthony HJC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements. The Cache County Study. Archives of Neurology, 2004;61:82-88.
Zi X, Feyes DK, Agarwal R. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468. Cancer Research, 1998;58: 1920-1929.
Chapter 7.
Anon. Brief cooking at low heat recommended for diabetics. Arizona Daily Star, November 12, 2002:A3.
Asami DK, Hong YJ, Barrett DM, et al. Comparison of the total phenolic and ascorbic acid content of freeze-dried and air-dried marionberry, strawberry, and corn grown using conventional, organic, and sustainable agriculture practices. Journal of Agricultural and Food Chemistry, 2003;51:1237-1241.
Goldman R, Shields PG. Food Mutagens. Journal of Nutrition, 2003;133(Suppl):965S-973S.
Hays JH, DiSabatino A, Gorman RT, et al. Effect of a high saturated fat and no-starch diet on serum lipid subfractions in patients with documental atherosclerotic cardiovascular disease. Mayo Clinic Proceedings, 2003;78;1331-1336.
Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. Journal of the American Medical Association, 2002;287:1815-1821.
Maresta A, Balduccelli M, Varani E, et al. Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for prevention of restenosis Italian study (ESPRIT). American Heart Journal, 2002;143:e5.
Nestel P, Shige H, Pomeroy S, et al. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase system arterial compliance in humans. American Journal of Clinical Nutrition, 2002;76:326-330.
Seddon JM, Cote J, Rosner B. Progression of Age-Related Macular Degeneration. Association with dietary fat, transunsaturated fat, nuts, and fish intake. Archives of Ophthalmology, 2003;121:1728-1737.
Uribarri J, Peppa M, Cai W, et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. Journal of the American Society of Nephrology, 2003;14:728-731.
Chapter 8.
No references.
Chapter 9.
Anon. Job stress affects 4 in 10 US workers. Reuters Health. January 26, 1999.
Anon. Chemical kin to pot tied to 'runner's high.' Arizona Daily Star, January 10, 2004:A2.
Anon. US workers too stressed to take vacation. Reuters Health, February 22, 2001.
Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology, 1995;32:98-105.
Benton D, Griffiths R, Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacology, 1997;129:66-71.
Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research, 2002;52:1-23.
Bower B. Worried to death: lifelong inhibitions hasten rodents' deaths. Science News, 2003;164:373.
Bjelland I, Tell GS, Vollset SE, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677CÑT polymorphism in anxiety and depression. Archives of General Psychiatry, 2003;60:618-626.
Brody S. High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial. Biological Psychiatry, 2002;52:371-374.
Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 2003;301:386-389.
Coe CL, Kramer M, Czeh B, et al. Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biological Psychiatry, 2003;54:1025-1034.
Elmadfa I, Jajchrzak D, Rust P, et al. The thiamine status of adult humans depends on carbohydrate intake. International Journal for Vitamin and Nutrition Research, 2001;71:217-221.
Johnston CS and Thompson LL. Vitamin C status of an outpatient population. Journal of the American College of Nutrition, 1998;17:366-370.
Kakuda T, Nozawa A, Unno T, et al Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem, 2000;64:287-293.
Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokines IL-6. Proceedings of the National Academy of Sciences, 2003:epub ahead of print.
Leventhal AG, Wang Y, Pu M, et al. GABA and its antagonists improved visual cortical function in senescent monkeys. Science, 2003;300:812-815.
Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences, 1997;93:3704-3709.
Meaney MJ, Weaver ICG, Szyf M. Maternal care permanently alters DNA structure and thus programs gene expression in brain regions that regulate stress responses. Unpublished abstract.
Moore DS. The Dependent Gene: The Fallacy of Nature vs. Nurture. New York: Henry Holt and Company, 2001: 119-120.
Palatnik A, Prolov K, Fux M, et al. Double-blind, controlled crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. Journal of Clinical Psychopharmacology, 2001;21:335-339.
Rosenkranz MA, Jackson DC, Dalton K, et al. Affective style and in vivo immune response: neurobehavioral mechanisms. Proceedings of the National Academy of Sciences, 2003:epub ahead of print.
Rossi E. The Psychobiology of Gene Expression. New York: W.W. Norton Professional Books: 2002.
Rossi E. The Psychobiology of Gene Expression: Neuroscience and Neurogenesis in Hypnosis and the Healing Arts. New York: W.W. Norton Professional Books, 2002.
Rossi E. The bioinformatics of psychosocial genomics in alternative and complementary medicine. Forschende Komplementarmedizin Klass Naturheilkunde, 2003:143-150.
Rozanski A, Blumnthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 1999;99:2192-2217.
Salzano J. Taming Stress. Scientific American, September 2003:87-95.
Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003;301:805-809.
Yokogoshi H, Kato Y, Sagesaka YM, et al. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci Biotechnol Biochem, 1995;59:615-618.
Wessel H. 40-hour week is just a mirage for many now. Arizona Daily Star, November 24, 2003:D1.
Williams RB, Carefoot JC, Schneiderman N. Psychological risk factors for cardiovascular disease. More than one culprit at work. JAMA, 2003;290:2190-2192.
Chapter 10.
Temple LK, McLeod RS, Gallinger S, et al. Defining disease in the genomics era. Science, 2001;293:807-808.
Aging.
Ames BN. Micronutrients prevent cancer and delay aging. Toxicology Letters, 1998;102-103:5-18.
Harman D. Free radical theory of aging. Mutation Research, 1992;275:257-66.
Harman D. Aging: phenomena and theories. Annals of the New York Academy of Sciences, 1998;854:1-7.
Purba M, Kouris-Blazos A, Wattanapenpaiboon N, et al. Skin wrinkling: can food make a difference? Journal of the American College of Nutrition, 2001;20:71-80
Alzheimer's Disease.
Bottiglieri T, Parnetti L, Arning E, et al. Plasma total homocysteine levels and the C677T mutation in the methylenetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mechanisms of Ageing and Development, 2001;122:2013-2023.
Clark R, Smith AD, Jobst KA, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease. Archives of Neurology, 1998;55:1449-1455.
Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer's disease. JAMA, 2002;287:3223-3229.
Hager K, Marahrens A, Kenklies M, et al. Alpha-lipoic acid as a new treatment option for Alzheimer type dementia. Archives of Gerontology and Geriatrics, 2001;32:275-282.
Kruman II, Kumaravel TS, Lohani A, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. Journal of Neuroscience, 2002;22:1752-1762.
LeBars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind randomized trial of an extract of Ginkgo biloba for dementia. JAMA, 1997;278:1327-32
Liu J, Head E, Gharib AM, et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-a-lipoic acid. Proceedings of the National Academy of Sciences, 2002;99:2356-2361.
Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science, 2003;302(5651):1760-1765.
Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer's disease in a biracial community study. JAMA, 2002;287:3230-3237.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine, 1997;336:1216-1222.
Selhub J, Bagley LC, Miller J, et al. B vitamins, homocysteine, and neurocognitive function in the elderly. American Journal of Clinical Nutrition, 2000;71(suppl):614S-620S.
Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 2002;346:476-483.
Wang HX, Wahlin A, Basun H, et al. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology, 2001;56:1188-1194.
Watanabe CMH, Wolffram S, Ader P, et al. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proceedings of the National Academy of Sciences, 2001;98:6577-6580.
Zandi PP, Anthony HJC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements. The Cache County Study. Archives of Neurology, 2004;61:82-88.
Birth Defects.
Bennett M. Vitamin B12 deficiency, infertility and recurrent fetal loss. Journal of Reproductive Medicine, 2001;46:209-212.
Botto, LD; Olney, RS; Erickson, JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. American Journal of Medical Genetics, Part CÑSeminars in Medical Genetics, 2004, 125C:21-21.
Bunin GR. Maternal diet during pregnancy and risk of brain tumors in children. International Journal of Cancer, 1998;11:23-25.
Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature, 1995; 378: 776-9.
Busciglio J, Pelsman A, Wong C, et al. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron, 2002; 33: 677-88.
Loffredo LCM, Souza JMP, Freitas JAS, et al. Oral clefts and vitamin supplementation. Cleft Palate Ð Cranialfacial Journal, 2001;38:76-83.
MacLeod K. Down Syndrome and Vitamin Therapy. Canada: Kemanso Publishing, 2003.
Pincheira J, Navarrete MH, de la Torre C, et al. Effects of vitamin E on chromosomal aberrations in lymphocytes from patients with Down's syndrome. Clinical Genetics, 1999;55:192-197.
Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. International Journal of Cancer, 1998;11:17-22.
Turkel H, Nusbaum I. Medical Treatment of Down Syndrome and Genetic Diseases. Southfield, Michigan: Ubiotica, 1985.
van Rooij IALM, Vermeij-Keers C, Kluijtmans LAJ, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymnorphisms affect the risk of cleft lip with or without cleft palate? American Journal of Epidemiology, 2003;157:583-591.
Shaw GM, Quach T, Nelson V, et al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. American Journal of Clinical Nutrition, 2003;78:972-978.
Cancer.
Boileau TWM, Liao Z, Kim S, et al. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)Ñtestosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. Journal of the National Cancer Institute, 2003;95:1578-1586.
Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 1996;276:1957-1963.
Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. Journal of the American College of Nutrition, 2003;22:118-123.
Fackelmann K. Viariations on a theme: interplay of genes and environment elevated cancer risk. Science News, May 6, 1995;147;280-281.
Gilliland FD, Li YF, Saxon A, et al. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomized, placebo-controlled crossover study. Lancet, 2004;363:119-125.
Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. Journal of the National Cancer Institute, 1995;87:1767-1776.
Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. Journal of the National Cancer Institute, 1999;91:317-331.
Hartman TJ, Albanes D, Pietinen P, et al. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiology, Biomarkers and Prevention, 1998;7:335-40.
Jolliet P, Simon N. Barre J, et al. Plasma Coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences. International Journal of Clinical Pharmacology and Therapeutics, 1998;36:506-509.
Kim YI, Pogribny IP, Basnakian AG, et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor genes. American Journal of Clinical Nutrition, 1997;65:46-52.
Kim YI. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutrition Reviews, 2000;58:205-217.
Kucuk O, Sarker FH, Djuric Z, et al. Effects of lycopene supplementation in patients with localized prostate cancer. Experimental Biology and Medicine, 2002;227:881-885.
Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10.. Biochemical and Biophysical Research Communications,1994;199:1504-8.
Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. New England Journal of Medicine, 2003;349:366-381.
Patterson RE, White E, Kristal AR, et al. Vitamin supplements and cancer risk: the epidemiological evidence. Cancer Causes and Control, 1997;8:786-802.
Polyak K, Xia Y, Zweier JL. A model for p53-induced apoptosis. Nature, 1997;389:300-305.
Prasad KN, Kumar B, Yan XD, et al. a-tocopherol succinate, the most effective for of vitamin E for adjuvant cancer treatment: a review. Journal of the American College of Nutrition, 2003;22:108-117.
Rudolph RE, Vaughan TL, Kristal AR, et al. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. Journal of the National Cancer Institute, 2003;95:750-757.
Wooster R, Weber BL. Breast and ovarian cancer. New England Journal of Medicine, 2003;348:2339-2347.
Cardiovascular Diseases.
Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet, 2000;356:1213-1218.
Boushey CJ, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA, 1995;274:1049-1057.
Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. New England Journal of Medicine, 2002;347:5-12.
Challem J and Dolby V, Homocysteine: The Secret Killer. New Canaan, Connecticut: Keats Publishing, 1997.
Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet, 1999;354:2048-2049.
Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. New England Journal of Medicine, 2004;350:29-37.
Fotherby MD, Williams JC, Forster LA, et al. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. Journal of Hypertension, 2000;18:411-415.
Hays JH, DiSabatino A, Gorman RT, et al. Effect of a high saturated fat and no-starch diet on serum lipid subfractions in patients with documental atherosclerotic cardiovascular disease. Mayo Clinic Proceedings, 2003;78;1331-1336.
Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. Journal of the American Medical Association, 2002;287:1815-1821.
Jialal I, Traber M, Deveraj S. Is there a vitamin E paradox? Current Opinion in Lipidology, 2001;12:49-53.
Kurl S, Tuomainen TP, Laukkanen JA, et al. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke, 2002;33:1568-1573.
Lobo A, Naso A, Aheart K, ÒReduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamin B6 and B12,Ó American Journal of Cardiology, 1999;83:821-825.
Loria CM, Ingram DD, Feldman JJ, et al. Serum folate and cardiovascular disease mortality among US men and women. Archives of Internal Medicine, 2000;160;3258-3262.
McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology, 1969;56:111-128.
McCully KS. Homocysteinemia and arteriosclerosis. American Heart Journal, 1972;83:571-573.
McCully KS. Homocystine, atherosclerosis and thrombosis: implications for oral contraceptive users. American Journal of Clinical Nutrition, 1975;28:542-549.
Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer's disease in a biracial community study. JAMA, 2002;287:3230-3237.
Morris MC, Evans DA, Bienias JL, et al. Vitamin E and cognitive decline in older persons. Archives of Neurology, 2002;59:1125-1132.
Nestel P, Shige H, Pomeroy S, et al. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase system arterial compliance in humans. American Journal of Clinical Nutrition, 2002;76:326-330.
Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA, 1997;278:1682-1686.
Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 2000;342:836-843.
Salonen JT, Nyyssonen K, Salonen R, et al. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. Journal of Internal Medicine, 2000;248:377-386.
Schnyder G, Roffi M, Flammer Y, et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamn B6 on clinical outcome after percutaneous coronary intervention. The Swiss heart study: A randomized controlled trial. JAMA, 2002;288:973-979.
Stephens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet, 1996;347:781-786.
Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 2002;325:1202-1208.
Warsi AA, Davies B, Morris-Stiff G. Abdominal aortic aneurysm and its correlation to plasma homocysteine and vitamins. European Journal of Vascular and Endovascular Surgery, 2004;27:75-79.
Yokoyama T, Date C, Kokubo Y, et al. Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community: the Shibata study. Stroke, 2000;31:2287-2294.
Cardiomyopathy and Heart Failure.
Bliznakov EG, Wilkins DJ. Biochemical and clinical consequences of inhibiting coenzyme Q10 biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): a critical overview. Advances in Therapy, 1998;15:218-228.
Brady JA, Rock CL, Horneffer MR. Thiamin status, diuretic medications, and the management of congestive heart failure. Journal of the American Dietetic Association, 1995;95:541-4.
Folkers K, Langsjoen P, Langsjoen PH. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant. Biochemical and Biophysical Research Communications, 1992; 182: 247-53.
Fosslien E. Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation. Annals of Clinical and Laboratory Science, 2003;33: 371-95.
Langsjoen PH, Langsjoen A, Willis R, et al. Treatment of hypertrophic cardiomyopathy with coenzyme Q10. Molecular Aspects of Medicine, 1997;18 (Suppl):S145-151.
Leslie D, Gheorghiade M. Is there a rle for thiamine supplementation in the management of heart failure. American Heart Journal, 19996;131:1248-1250.
Rieck J, Halkin H, Almog S, et al. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. Journal of Laboratory and Clinical Medicine, 1999;134:238-243.
Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. American Heart Journal, 2000;139:S120-S123.
Sarter B. Coenzyme Q10 and cardiovascular disease: a review. Journal of Cardiovascular Nursing, 2002; 16: 9-20.
Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. American Journal of Medicine, 1995;98:485-90.
Sole MJ, Jeejeebhoy KN. Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz, 2002; 27: 174-8.
Celiac Disease.
Banco G. Conditions and disorders associated with celiac disease. Journal of Pediatric Gastroenterology and Nutrition, 2000;31(Suppl 3):S28, Abstract #100.
Braly J, Hoggan R. Dangerous Grains. New York: Penguin Putnam, 2002.
Cicarelli G, Della Rocca G, Amboni M, et al. Clinical and neurological abnormalities in adult celiac disease. Neurological Sciences, 2003;24:311-317.
Cordain L. Miller JB, Eaton SB, et al. Plant-animal subsistence ratios and macronutrient energy estimates in worldwide hunter-gatherer diets. American Journal of Clinical Nutrition, 2000;71:682-692.
Eaton SB, Eaton SB II. Paleolithic vs. modern dietsÑselected pathophysical implications. European Journal of Nutrition, 2000;39:67-70.
Fasano A. Celiac diseaseÑhow to handle a clinical chameleon. New England Journal of Medicine, 2003;348:2568-2570.
Johnson-Kelly LW. The evolutionary history of celiac disease. Journal of Pediatric Gastroenterology and Nutrition, 2000;31(Suppl 3):S10, Abstract #27.
Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Gluten sensitivity: a many headed hydra. BMJ, 1999;318:1710-1711.
Harder B. Target: celiac disease. Science News, June 21, 2003:392-393.
McManus R, Kelleher D. Celiac diseaseÑthe villain unmasked? New England Journal of Medicine,2003;348:2573-2574.
Smith MD. Going Against the Grain. Chicago: Contemporary Books, 2002.
Depression and Moodiness.
Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology, 1995;32:98-105.
Benton D, Griffiths R, Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacology, 1997;129:66-71.
Bjelland I, Tell GS, Vollset SE, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677CÑT polymorphism in anxiety and depression. Archives of General Psychiatry, 2003;60:618-626.
Brenner R, Azbel V, Madhusoodanan S, et al. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clinical Therapeutics, 2000;22:411-419.
Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 2003;301:386-389.
Schrader E. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized controlled study in mild-moderate depression. International Clinical Psychopharmacology, 2000;15:61-68.
Fatigue and Chronic Fatigue.
Barbiroli B, Medori R, Tritschler HJ, et al. Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy. Journal of Neurology, 1995;242:472-477.
Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Annals of Allergy, Asthma, and Immunology, 1999;82:185-191.
Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. Journal of the Royal Society of Medicine, 1999;92:183-185.
Johnston CS and Thompson LL, ÒVitamin C status of an outpatient population,Ó Journal of the American College of Nutrition, 1998;17:366-370.
Plioplys AV and Sigita Plioplys. Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology, 1997;35:16-23.
Langsjoen P. Coenzyme Q10. Presented at the 4th Annual Conference on Anti-Aging Medicine and Biomedical Technology, Las Vegas, Nevada, Dec 14-16, 1996.
Sinatra ST. Coenzyme Q10: a vital therapeutic nutrient for the heart with special application in congestive heart failure. Connecticut Medicine, 1997; 61:707-11.
Hemochromatosis.
Heath ALM, Fairweather SJ. Health implications of iron overload: the role of diet and genotype. Nutrition Reviews, 2003;61:45-62.
Kaltwasser JP, Werner E, Schalk K, et al. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut, 1998; 43: 699-704.
Inflammatory Diseases.
Box HC, MacCubbin AE. Lipid peroxidation and DNA damage. Nutrition, 1997;13:920-921.
Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radical Biology & Medicine, 2000; 29:790-792.
Edmonds SE, Yinyard PG, Guo R, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Annals of the Rheumatic Diseases, 1997;56:649-655.
Curtis CL, Hughes CE, Flannery CR, et al. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. Journal of Biological Chemistry, 2000;275:721-724.
Helmy M, Shohayeb M, Helmy MH, et al. Antioxidants as adjuvant therapy in rheumatoid diseaseÑa preliminary study. Arzneimittel-Forschung/Drug Research, 2001;51:293-298.
Jenkinson AM, Collins AR, Duthie SJ, et al. The effect of increased intakes of polyunsaturated fatty acids and vitamin E on DNA damage in human lymphocytes. FASEB Journal, 1999;13:2138-2142.
Kornman KS, Martha PM, Duff GW. Genetic variations and inflammation: a practical nutrigenomics opportunity. Nutrition, 2004;20:44-49.
Lau CS, Morley KD, Belch JJF. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritisÑa double-blind placebo controlled study. British Journal of Rheumatology, 1993;32:982-989.
Linos A, Kaklamani VG, Kaklamani E, et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables. American Journal of Clinical Nutrition, 1999;70:1077-1082.
Liu S, Manson JE, Buring J, et al. A high glycemic diet in relation to plasma levels of high-sensitivity c-reactive protein in middle-aged women. American Journal of Epidemiology, 2001;153 (Suppl 11):S97.
Leventhal LL, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Annals of Internal Medicine, 1993;9:867-873.
Upritchard JE, Sutherland WHF, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care, 2000, 23:733-738.
Zurier RB, Rossetti RG, Jacobson EW, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled study. Arthritis & Rheumatism, 1996;11:1808-1817.
Osteoporosis.
Dimai HP, Porta S, Wirmsberger G, et al. Daily oral magnesium supplementation suppresses bone turnover in young adult males. Journal of Clincal Endocrinology and Metabolism, 1998;83:2742-2748.
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, D.C.: National Academy Press, 1997.
Guillemant J, Le H-T, Accarie C, et al. Mineral water as a source of dietary calcium: acute effects on parathyroid function and bone resorption in young men. American Journal of Clinical Nutrition, 2000;71:999-1002.
Hegarty VM, May HM, Khaw K-T. Tea drinking and bone mineral density in older women. American Journal of Clinical Nutrition, 2000;71:1003-1007
Kim GS, Kim CH, Park JY, et al. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism, 1996;45:1443-6.
MŸhlbauer RC and Li F. Effect of vegetables on bone metabolism. Nature, 1999;401:343-344
New SA, Robins SP, Campbell MK, et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health. American Journal of Clinical Nutrition, 2000;71:142-151
Recer P. Americans said to need calcium. Associated Press, August 14, 1997.
Sokoll LJ, Booth SL, O'Brien ME, et al. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. American Journal of Clinical Nutrition, 1997;65:779-84.
The Vitamin D Quandary.
Bortman P, Folgueira MA, Katayama ML, et al. Antiproliferative effectives of 1,25-hydroxyvitamin D3 on breast cells: a mini review. Brazilian Journal of Medical and Biological Research, 2002;35:1-9.
Bretherton-Watt D, Given-Wilson R, Mansi JL, et al. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. British Journal of Cancer, 2001, 85:171-175.
Hayes CE. Vitamn D: national inhibitor of multiple sclerosis. Proceedings of the Nutrition Society, 2000;59:531-535.
Hou MF, Tien YC, Lin GT, et al. Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Research and Treatment, 2002;74:1-7.
Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science, 2002;296:1313-1316.
Ogata E. The potential use of vitamin D analogs in the treatment of cancer. Calicified Tissue International, 1997;60:130-133.
Ortlepp JR, Lauscher J, Hoffman R, et al. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabetic Medicine, 2001;18:842-845.
Pani MA, Seissler J, Usadel KH, et al. Vitamin D receptor genotype is associated with Addison's disease. European Journal of Endocrinology, 2002;147:635-640.
Saeki H, Asano N, Tsunemi Y, et al. Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. Journal of Dermatological Science, 2002;30:167-171.
Sheehan D, Bennett T, Cashman K. The genetics of osteoporosis: vitamin D receptor gene polymorphisms and circulating osteocalcin in healthy Irish adults. Irish Journal of Medical Science, 2001;170:54-57.
Sheehan D, Bennett T, Cashman KD. An assessment of genetic markers as predictors of bone turnover in healthy adults. Journal of Endocrinological Investigation, 2001;24:236-245.
Sun JL, Meng HX, Cao CF, et al. Relationship between vitamin D receptor gene polymorphism and periodontitis. Journal of Periodontal Research, 2002;37:263-267.
Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QMJÐA Quarterly Journal of Medicine, 2002;95:787-796.
Xu Y, Shbiata A, McNeal JE, et al. Vitamin D receptor start codon polymorphisms (Fokl) and prostate cancer progression. Cancer Epidemiology Biomarkers and Prevention, 2003;12:23-27.
Zitterman A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology, 2003;41:105-112.
Obesity and Type 2 Diabetes.
Anderson RA, Chen N, Bryden NA, et al., ÒElevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes,Ó Diabetes, 1997;46:1786-1791.
Anon. Obesity in U.S. has surged, survey says. Reuters Health, October 8, 2002.
de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population. The Hoorn study. JAMA, 2001;285:2109-2113.
Diamond J. The double puzzle of diabetes. Nature,2003;423:599602.
Khan A, Safdar M, Khan MMA, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care, 2003;26:3215-3218.
Khaw KT, Wareham N, Luben R, et al. Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investivations of cancer and nutrition (EPIC-Norfolk). BMJ, 2001;322;1-6.
Johnston CS, Kim CM, Buller AJ. Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes. Diabetes Care, 2004;27:281-282.
Ludwig DS. The glycemic index. Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA, 2002;287:2414-2423.
McConnaughey J. CDC projection points to tripling of U.S. Diabetes. Arizona Daily Star (Associated Press), June 15, 2003:A1.
Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care, 2000;23:1278-1283.
McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacology for dysthymic disorder in 5 patients. Journal of Clinical Psychiatry, 1999;60:237-240.
McLeod MN, Golden RN. Chromium treatment of depression. International Journal of Neuropsychopharmacology;2000;3:311-314.
Peterson KF, DuFour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistance offspring of patients with type 2 diabetes. New England Journal of Medicine, 2004;350:664-671.
Velussi M, Cernigoi AM, De Monte AD, et al., ÒLong-term (12 months) treatment with an antioxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients,Ó Journal of Hepatology, 1997;26:871-879.
Parkinson Disease.
Chen H, Zhang SM, Hernan MA, et al. Diet and Parkinson's disease: a potential role of dairy products in men. Annals of Neurology, 2002;52:793-801.
Ciccone CD. Free-radical toxicity and antioxidant medications in Parkinson's disease. Physical Therapy, 1998;78:313-319.
de Rijk MC, Breteler MMB, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease. Archives of Neurology, 1997;54:762-765.
Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. Journal of Neurochemistry, 2002;80:101-110.
Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease I: a possible role for the past intake of specific foods and food groups. Neurology, 1996;47:636-643.
Hellenbrand W, Boeing H, Robra BP, et al. Diet and Parkinson disease II: a possible role for the past intake of specific nutrients. Neurology, 1996;47:644-650.
Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease. Evidence of slowing of the functional decline. Archives of Neurology, 2002;59:1541-1550.
Zhang SM, Hernan MA, Chen H, et al. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology, 2002;59:1161-1169.
Pyroluria.
Jackson JA, Riordan HD, Neathery S, et al. Urinary pyrrole in health and disease. Journal of Orthomolecular Medicine, 1997;12:96-98
Jackson JA, Riordan HD, Neathery S, et al. Urine pyrroles revisited. Journal of Orthomolecular Medicine, 2001;16:47-48
Sickle-Cell Anemia.
Kennedy TS, Fung EB, Kawchak DA, et al. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 2001;23:165-169.
Marwah, SS; Wheelwright, D; Blann, et al. Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease. British Journal of Haematology, 2001;114:917-919
Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition, 2000;16:330-338.
Ohnishi ST, Ohnishi T, Ogunmola GB. Green tea extract and aged garlic extract inhibit anion transport and sickle cell dehydration in vitro. Blood Cells, Molecules, and Diseases, 2001;27:148-157.
Shukla P, Graham SM, Borgstein A, et al. Sickle cell disease and vitamin E deficiency in children in developing countries. Transactions of the Royal Society of Tropical Medicine, 2000, 94:109.
Skin Aging and Wrinkles.
Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Archives of Dermatology, 2002;138:1462-1470.
Eberlein-Kšnig B, Placzek M, and Pryzybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-a-tocopherol (vitamin E). Journal of the American Academy of Dermatology, 1998;38:45-48.
Heinrich U, Gartner C, Wiebusch M, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. Journal of Nutrition, 2003;133:98-101.
Lee J, Jiang S, Levine N, et al. Carotenoid supplementation reduces erythema in human skin after simulated Solar Radiation Exposure. Proceedings of the Society for Experimental Biology and Medicine, 2000,223:170-174
Purba M, Kouris-Blazos A, Wattanapenpaiboon N, et al. Skin wrinkling: can food make a difference? Journal of the American College of Nutrition, 2001;20:71-80.
Saliou C, Rimbach G, Moini H, et al. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radical Biology and Medicine, 2001;30;154-160
Thiele J, Elsner P. Oxidants and Antioxidants in Cutaneous Biology. Basel: Karger, 2001.
Trekli MC, Riss G, Goralczyk, et al. Beta-carotene suppresses UVA-induced HO-1 gene expression in cultured FEK4. Free Radical Biology & Medicine, 2003;34:456-464.